Repeated exposure to ozone increases alveolar macrophage recruitment into asthmatic airways. 2005

Mehrdad Arjomandi, and Allyson Witten, and Emilio Abbritti, and Kurt Reintjes, and Isabelle Schmidlin, and Wenwu Zhai, and Colin Solomon, and John Balmes
Lung Biology Center, Department of Medicine, University of California, San Francisco, CA 94143, USA.

BACKGROUND Repeated, short-term exposures to ozone (O3) lead to attenuation of the acute lung function and airway inflammatory responses seen after a single exposure in healthy subjects, but it is unclear whether these acute responses also attenuate in subjects with asthma. OBJECTIVE To address this question by exposing 14 subjects with asthma to 0.2 ppm O3 for either 4 hours on a single day or 4 hours on 4 consecutive days (multiday [MD]). At least 3 weeks later, subjects underwent the alternate exposure. METHODS Spirometry was performed immediately pre- and postexposure and bronchoalveolar lavage (BAL) was obtained 18 hours after each exposure. RESULTS The decrease in FEV1 was greatest across Day 2 of the MD (MD2) exposure and then gradually declined on successive days of the MD exposure (mean +/- SD decrease in FEV1 of 25.4 +/- 18.0% across MD2 compared with 4.2 +/- 6.5% across MD4). Respiratory symptoms followed a similar pattern to that of FEV1. Although the concentration of neutrophils in BAL after the MD4 exposure was not significantly different from that after the single-day exposure (1.7 +/- 1.3 x 10(4) cells/ml vs. 1.2 +/- 0.8 x 10(4) cells/ml, p = 0.20), the concentration of alveolar macrophages did significantly increase in BAL after the MD exposure (19.9 +/- 9.7 x 10(4) cells/ml after MD4 vs. 12.1 +/- 6.4 x 10(4) cells/ml after the single day). CONCLUSIONS Alveolar macrophages are recruited to the airways of subjects with asthma with repeated short-term exposures to O3, suggesting a possible role for these cells in the chronic response to oxidant-induced injury.

UI MeSH Term Description Entries
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008297 Male Males
D010126 Ozone The unstable triatomic form of oxygen, O3. It is a powerful oxidant that is produced for various chemical and industrial uses. Its production is also catalyzed in the ATMOSPHERE by ULTRAVIOLET RAY irradiation of oxygen or other ozone precursors such as VOLATILE ORGANIC COMPOUNDS and NITROGEN OXIDES. About 90% of the ozone in the atmosphere exists in the stratosphere (STRATOSPHERIC OZONE). Ground Level Ozone,Low Level Ozone,Tropospheric Ozone,Level Ozone, Ground,Level Ozone, Low,Ozone, Ground Level,Ozone, Low Level,Ozone, Tropospheric
D001992 Bronchoalveolar Lavage Fluid Washing liquid obtained from irrigation of the lung, including the BRONCHI and the PULMONARY ALVEOLI. It is generally used to assess biochemical, inflammatory, or infection status of the lung. Alveolar Lavage Fluid,Bronchial Lavage Fluid,Lung Lavage Fluid,Bronchial Alveolar Lavage Fluid,Lavage Fluid, Bronchial,Lavage Fluid, Lung,Pulmonary Lavage Fluid,Alveolar Lavage Fluids,Bronchial Lavage Fluids,Bronchoalveolar Lavage Fluids,Lavage Fluid, Alveolar,Lavage Fluid, Bronchoalveolar,Lavage Fluid, Pulmonary,Lavage Fluids, Alveolar,Lavage Fluids, Bronchial,Lavage Fluids, Bronchoalveolar,Lavage Fluids, Lung,Lavage Fluids, Pulmonary,Lung Lavage Fluids,Pulmonary Lavage Fluids
D001999 Bronchoscopy Endoscopic examination, therapy or surgery of the bronchi. Bronchoscopic Surgical Procedures,Surgical Procedures, Bronchoscopic,Bronchoscopic Surgery,Surgery, Bronchoscopic,Bronchoscopic Surgeries,Bronchoscopic Surgical Procedure,Bronchoscopies,Surgeries, Bronchoscopic,Surgical Procedure, Bronchoscopic
D005260 Female Females
D005541 Forced Expiratory Volume Measure of the maximum amount of air that can be expelled in a given number of seconds during a FORCED VITAL CAPACITY determination . It is usually given as FEV followed by a subscript indicating the number of seconds over which the measurement is made, although it is sometimes given as a percentage of forced vital capacity. Forced Vital Capacity, Timed,Timed Vital Capacity,Vital Capacity, Timed,FEVt,Capacities, Timed Vital,Capacity, Timed Vital,Expiratory Volume, Forced,Expiratory Volumes, Forced,Forced Expiratory Volumes,Timed Vital Capacities,Vital Capacities, Timed,Volume, Forced Expiratory,Volumes, Forced Expiratory
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas

Related Publications

Mehrdad Arjomandi, and Allyson Witten, and Emilio Abbritti, and Kurt Reintjes, and Isabelle Schmidlin, and Wenwu Zhai, and Colin Solomon, and John Balmes
December 1997, Toxicology and applied pharmacology,
Mehrdad Arjomandi, and Allyson Witten, and Emilio Abbritti, and Kurt Reintjes, and Isabelle Schmidlin, and Wenwu Zhai, and Colin Solomon, and John Balmes
February 2010, Inhalation toxicology,
Mehrdad Arjomandi, and Allyson Witten, and Emilio Abbritti, and Kurt Reintjes, and Isabelle Schmidlin, and Wenwu Zhai, and Colin Solomon, and John Balmes
October 2019, Journal of visualized experiments : JoVE,
Mehrdad Arjomandi, and Allyson Witten, and Emilio Abbritti, and Kurt Reintjes, and Isabelle Schmidlin, and Wenwu Zhai, and Colin Solomon, and John Balmes
December 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology,
Mehrdad Arjomandi, and Allyson Witten, and Emilio Abbritti, and Kurt Reintjes, and Isabelle Schmidlin, and Wenwu Zhai, and Colin Solomon, and John Balmes
September 1990, The Journal of allergy and clinical immunology,
Mehrdad Arjomandi, and Allyson Witten, and Emilio Abbritti, and Kurt Reintjes, and Isabelle Schmidlin, and Wenwu Zhai, and Colin Solomon, and John Balmes
September 1991, Toxicology and applied pharmacology,
Mehrdad Arjomandi, and Allyson Witten, and Emilio Abbritti, and Kurt Reintjes, and Isabelle Schmidlin, and Wenwu Zhai, and Colin Solomon, and John Balmes
January 1997, Archives of environmental health,
Mehrdad Arjomandi, and Allyson Witten, and Emilio Abbritti, and Kurt Reintjes, and Isabelle Schmidlin, and Wenwu Zhai, and Colin Solomon, and John Balmes
January 1991, Experimental lung research,
Mehrdad Arjomandi, and Allyson Witten, and Emilio Abbritti, and Kurt Reintjes, and Isabelle Schmidlin, and Wenwu Zhai, and Colin Solomon, and John Balmes
February 1998, Toxicological sciences : an official journal of the Society of Toxicology,
Mehrdad Arjomandi, and Allyson Witten, and Emilio Abbritti, and Kurt Reintjes, and Isabelle Schmidlin, and Wenwu Zhai, and Colin Solomon, and John Balmes
August 1994, American journal of respiratory and critical care medicine,
Copied contents to your clipboard!